Optimizing early treatment central in reducing burden of resistant depression

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.


1. Heerlein K et al. J Affect Disord 2021 Mar 15;283:115-122. doi: 10.1016/j.jad.2020.11.124.

2. Bartova L et al. World J Biol Psychiatry 2019; 20: 427-448

3. Lépine J-P, Briley M. Neuropsychiatr Dis Treat 2011; 7(Suppl 1): 3-7

4. Demyttenaere K, Van Duppen Z. Int J Neuropsychopharmacol 2019; 22: 85-92

5. Jaffe DH et al. BMC Psychiatry 2019 Aug 7;19(1):247

6. Bukh JD et al. J Affect Disord 2013; 145 :42-8

7. Kennedy SH et al. Can J Psychiatry 2016; 61: 540–56

8. Drysdale AT et al. Nat Med 2017; 23: 28-38

9. Fu CHY et al. Neurobiol Dis 2013; 52: 75-83

10. Cattaneo A et al. Neuropsychopharmacology 2013;38:377-85

11. Chamberlain SR et al. Br J Psychiatry 2019; 214: 11-19

Du lämnar Progress in Mind Sverige
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
Den här informationen är endast avsedd för hälso- och sjukvårdspersonal
Register for access to Progress in Mind in your country